epidermal growth factor receptor tyrosine kinase inhibitors - Globe Thesis

Keyword [epidermal growth factor receptor tyrosine kinase inhibitors] Result: 21 - 37 \| Page: 2 of 2
21.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
22.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
23.	Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
24.	MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
25.	Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
26.	Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
27.	Clinical Outcomes Of Surgery Combined With Targeted Therapy In Non-Small Cell Lung Cancer
28.	Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population
29.	Study On The Changes Of Plasma T790M Gene Mutation After TKI Therapy In Patients With Advanced Non-small Cell Lung Cancer
30.	Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma
31.	The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC
32.	The Relationship Between NLR & FIB And Prognosis Of Targeted Treatment In Advanced Lung Adenocarcinoma With EGFR Mutation
33.	A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma
34.	MiR-206 Involved In Gefitinib Acquired Drug-resistance In Non-small Cell Lung Cancer Patients Through Modulating IL-6 Expression
35.	Clinical And Translational Study Of Delayed EGFR-TKI Acquired Resistance By Radiotherapy In Non-small-cell Lung Cancer
36.	Detection Of Prognostic Indicators And Survival Analysis In Patients With EGFR Mutant Lung Adenocarcinoma
37.	The Impact Of Cocurrent Alterations On EGFR-TKIs Efficacy And Progression Patterns After Drug Resistance In Advanced EGFR-mutant NSCLC Patients
<<First <Prev Next> Last>> Jump to